Tretinoin
NDC 62032-413, Tretinoin, gel, from Obagi Cosmeceuticals LLC.
- Product NDC
- 62032-413
- Status
- Listed
- Labeler
- Obagi Cosmeceuticals LLC
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA022070
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62032-413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRETINOIN.05 g/100g
Pharmacologic classes
Retinoid [EPC]; Retinoids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62032-413-20 | 62032041320 | 20 g in 1 TUBE (62032-413-20) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c5ee36ac-2ffd-4cca-ad47-b1dae7ebdb3b
Use it
Look up 62032-413 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62032-413 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62032-413. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.